NSIS-B:CPH
Novozymes A/S
DKKÂ 454.80
arrow_downward
-0.70%(-3.20) Siku 1
16 Okt, 17:00:00 GMT +2 · DKK
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya NSIS-B...
Fungua
DKKÂ 452.80
Juu
DKKÂ 456.80
Chini
DKKÂ 452.00
Mtaji wa soko
183.47B
Wastani wa kiasi cha mauzo
elfu 605.45
Kiasi cha mauzo ya hisa
elfu 954.34
Juu kwa wiki 52
DKKÂ 465.00
Chini kwa wiki 52
DKKÂ 336.80
Hisa za wawekezaji
414.56M
Idadi ya wafanyakazi
elfu 11
Fungua
DKKÂ 452.80
Juu
DKKÂ 456.80
Chini
DKKÂ 452.00
Mtaji wa soko
183.47B
Wastani wa kiasi cha mauzo
elfu 605.45
Kiasi cha mauzo ya hisa
elfu 954.34
Juu kwa wiki 52
DKKÂ 465.00
Chini kwa wiki 52
DKKÂ 336.80
Hisa za wawekezaji
414.56M
Idadi ya wafanyakazi
elfu 11
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
ad-hoc-news.de
·
siku 1 iliyopita
Novonesis stock stands 1.27 percent below its 52-week high
Wasifu
Novonesis is a biotechnology company headquartered in Lyngby, Denmark. Novonesis was formed in 2024 through the merger of Novozymes and Chr. Hansen.
The company develops enzymes, microbial cultures, and other biological products used in food and beverage production, household products, agriculture, and bioenergy.
The merger, first announced in December 2022, was the largest merger in history between two Danish companies. It would combine Novozymes' industrial-enzyme business with Chr. Hansen's microbial cultures and food-ingredient operations.
The company is publicly traded on Nasdaq Copenhagen and is part of the OMX Copenhagen 25 Index. The company's largest shareholder is Novo Holdings A/S, which is owned by the Novo Nordisk Foundation.
As of 2025, Novonesis has more than 11,000 employees and activities in over 45 countries. Wikipedia
Kuhusu Novozymes A/S
Afisa Mkuu Mtendaji (CEO)Ester Baiget
Wafanyakazielfu 11.1
Lilianzishwa2000
Makao makuu-
SektaSpeciality chemicals
Tovutinovonesis.com